Expert Group meeting with the management of EGFR mutation positive NSCLC - Part II

Speciality: Ophthalmology


Speaker:

Dr. Abhishek Bansal ( Panelist ) | Consultant Medical Oncologist, SSB Heart And Multispeciality Hospital, Fridabad.

Dr. Atul Sharma ( Panelist ) | Senior Consultant Medical Oncologist, Jaypee Hospital, Noida

Dr. Vineet Govinda Gupta ( Moderator ) | Senior Consultant Medical Oncologist

Description:

A warm welcome to all the medical professionals in this interesting session on Expert group convenes to discuss management strategies for EGFR mutation-positive NSCLC.

The Expert Group meeting on the management of EGFR mutation-positive non-small cell lung cancer (NSCLC) convenes to address critical aspects of treatment strategies, therapeutic advancements, and patient care. Participants, including leading oncologists, researchers, and healthcare professionals, gather to discuss the latest developments in targeted therapies, molecular diagnostics, and personalized medicine for patients with EGFR mutation-positive NSCLC.

The meeting aims to foster collaboration, exchange scientific insights, and explore innovative approaches to optimize patient outcomes and quality of life. Through comprehensive discussions, evidence-based presentations, and case studies, the Expert Group endeavors to refine treatment algorithms, identify emerging challenges, and propose novel solutions to enhance the standard of care for individuals affected by EGFR mutation-positive NSCLC.

Ultimately, the collaborative efforts of the Expert Group contribute to advancing the field of oncology and improving the prognosis and management of EGFR-driven NSCLC.

Therefore, get an overall knowledge on Expert group convenes to discuss management strategies for EGFR mutation-positive NSCLC. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions.


See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Patients face high out-of-pocket costs after incident cancer diagnosis

2.

In a study, immune detection of oral cancers is linked to obesity.

3.

Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.

4.

Every cancer is different because of how evolution causes drug resistance and why various cancers require various treatments.

5.

Common intracellular toxin could help fight leukemia


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot